This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marques da Silva, S. H. Articles by Pires de Camargo, Z. Search for Related Content PubMed PubMed Citation Articles by Marques da Silva, S. H. Articles by Pires de Camargo, Z.

Detection of Paracoccidioides brasiliensis gp70 Circulating Antigen and Follow-Up of Patients Undergoing Antimycotic Therapy

Department of Microbiology, Immunology and Parasitology,¹ Department of Infectious Disease, Federal University of São Paulo, São Paulo,² Department of Clinical Pathology, Medical School, State University of Campinas, Campinas, São Paulo,³ Department of Community Health, Medical School, Federal University of Paraná, Curitiba, Paraná, Brazil⁴

Received 22 March 2004/ Returned for modification 5 April 2004/ Accepted 18 June 2004

Paracoccidioidomycosis (PCM), one of the most important systemic mycoses in Central and South America, is caused by the dimorphic fungus Paracoccidioides brasiliensis and has a high prevalence in Brazil. Glycoproteins of 43 and 70 kDa are the main antigenic compounds of P. brasiliensis and are recognized by Western blotting by 100 and 96% of PCM patient sera, respectively. In the present study, an inhibition enzyme-linked immunosorbent assay (ELISA) was used to detect gp70 in different biological samples from patients with PCM. gp70 was detected in 98.76% of 81 serum samples, with an average concentration of 8.19 µg/ml. The test was positive for 100% of the patients with the acute and chronic unifocal forms of PCM and 98.43% of the patients with the multifocal chronic form, with average concentrations of 11.86, 4.83, and 7.87 µg/ml, respectively. Bronchoalveolar lavage fluid from 23 patients with pulmonary unifocal PCM and 14 samples of cerebrospinal fluid from patients with neurological PCM were also tested for gp70 detection, with the test showing 100% sensitivity and 100% specificity, with mean gp70 concentrations of 7.5 and 6.78 µg/ml, respectively. To investigate the potential of gp70 detection by inhibition ELISA for the follow-up of PCM patients during antimycotic therapy with itraconazole (ITZ), the sera of 23 patients presenting with the chronic multifocal form of PCM were monitored at regular intervals of 1 month for 12 months. The results showed a decrease in circulating gp70 levels during treatment which paralleled the reduction in anti-P. brasiliensis antibody levels. The detection of P. brasiliensis gp70 from the biological fluids of patients suspected of having PCM proved to be a promising method for diagnosing infection and evaluating the efficacy of ITZ treatment.

This article has been cited by other articles:

• Marques-da-Silva, S. H., Colombo, A. L., Blotta, M. H. S. L., Queiroz-Telles, F., Balthazar, A. B., Lopes, J. D., de Camargo, Z. P. (2006). Diagnosis of Paracoccidioidomycosis by Detection of Antigen and Antibody in Bronchoalveolar Lavage Fluids. CVI 13: 1363-1366 [Abstract] [Full Text]  
• Silva, S. H. M. d., Colombo, A. L., Blotta, M. H. S. L., Queiroz-Telles, F., Lopes, J. D., Camargo, Z. P. d. (2005). Diagnosis of Neuroparacoccidioidomycosis by Detection of Circulating Antigen and Antibody in Cerebrospinal Fluid. J. Clin. Microbiol. 43: 4680-4683 [Abstract] [Full Text]